Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases. Founded by Lewis Cantley and Nathanael Gray in 2016, Petra Pharma Corporation is backed by investors that include AbbVie, Alexandria Venture, ARCH Venture Partners, Eli Lilly, and Johnson & Johnson Innovation and is headquartered in New York.